SCHEMBL2315809

SCHEMBL2315809

CC(F)Cc1nc(N)sc1C(=O)c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.43
RAB9A P51151 3/20 0.43
DUSP3 P51452 1/20 0.43
CCNA2 P20248 2/20 0.43
CDK2 P24941 2/20 0.43
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
CDK5 Q00535 3/20 0.42
CDK5R1 Q15078 3/20 0.42
MAPT P10636 8/20 0.41
LMNA P02545 2/20 0.39
HPGD P15428 2/20 0.39
USP2 O75604 1/20 0.39
MCL1 Q07820 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 2/20 0.38
ALDH1A1 P00352 2/20 0.37
ALOX12 P18054 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8694581 0.81 CCNA2 (0.47) NPC1RAB9ADUSP3CCNA2CDK2
SCHEMBL8698915 0.78 KDM4E (0.47) NPC1RAB9ADUSP3CCNA2CDK2
SCHEMBL13536655 0.74 HPGD (0.49) NPC1RAB9ADUSP3CCNA2CDK2
SCHEMBL2315038 0.73 CCNA2 (0.47) NPC1RAB9ADUSP3CCNA2CDK2
SCHEMBL2315805 0.73 NPC1 (0.45) NPC1RAB9ADUSP3CCNA2CDK2
SCHEMBL2315072 0.72 CCNA2 (0.46) NPC1RAB9ADUSP3CCNA2CDK2
SCHEMBL3185793 0.70 DRD4 (0.47) NPC1RAB9ADUSP3CCNA2CDK2
SCHEMBL14264449 0.67 FBP1 (0.47) NPC1RAB9ADUSP3CCNA2CDK2
SCHEMBL257436 0.65 RORB (0.66) MEN1KMT2AMAPTLMNATP53
SCHEMBL13638641 0.65 MEN1 (0.51) NPC1RAB9ACCNA2CDK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349484-A2 HETEROARYL DERIVATIVES AS DGAT1 INHIBITORS Novartis AG (CH) 2011-08-03 EP disclosed
WO-2010007046-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-01-21 WO disclosed